Anti-infective drugs Market: Global Industry Analysis and forecast (2023 to 2029)


Anti-infective drugs Market size is expected to reach US$ 215.36 Bn. by year 2029 at a CAGR of 8% during the forecast period.

Anti-infective drugs Market Drivers and Restrains

The technological advances in anti-viral and antibiotic compounds are currently anti-infective drugs market, including Truvada and Valtrex, which are anti-HIV and anti-herpes therapy drugs, which are expected to fuel global anti-infective drug market.

Anti-infective drug is capable of acting against infection by inhibiting the spread of an infectious agent or by killing the infectious agent outright.It is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.Anti-infective-drugs-MarketTo know about the Research Methodology :- Request Free Sample Report

Developments such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems would propel the global anti-infective drugs market. Factors such as patent expiration of drugs, pricing pressures from regulators, and low returns on investments would hinder the global Anti-infective drugs market in forecast period.

In January 2018, Melinta Therapeutics, Inc. launched its intravenous and oral formulations of Baxdela (delafloxacin) in the U.S. Baxdela is intended for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria including gram positive bacteria and gram negative bacteria. This step would drive the global Anti-infective drugs market and is anticipated to maintain its dominance in forecast period.

Anti-infective drugs Market key segmentation

The antibiotics market is further segmented by product into -lactams, quinolones, macrolides, aminoglycosides and others. The antivirals market is further segmented by therapeutic type into HIV AIDS therapeutics, hepatitis therapeutics, influenza therapeutics, and herpes therapeutics. The antifungals market is further segmented by product into azoles and others. The Antibacterial market is further segmented as Aminoglycosides, Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, Sulfonamides, Tetracyclines and Others Calcium channel blockers.

Antiviral drug held highest share in terms of revenue of global Anti-infective drugs Market during the forecast period. rapid increase in the access to antiviral treatment of sexually transmitted diseases such as Hepatitis B and HIV/AIDS is expected to fuel this segment..
Increase in number of medical stores and hospitals are responsible for growth global Anti-infective drug market. Strong network of distribution channels around the countries have attributed to availability of anti-infectives that will affect the market in positive way. Also, major market players are focusing on expanding its geographical regions by focusing on distribution of anti-infectives in untapped markets of developing countries.

The hospitals provide extensive patient treatment, care, quick reimbursement, and insurance policies owing to which patients opt for hospital pharmacies.

Anti-infective drugs Market regional analysis

North America dominated the global anti-infective drug market in 2022. Changing healthcare market scenario and high awareness among end-users such as clinicians and healthcare professionals are estimated key factors responsible for this growth rate. Furthermore, high purchasing power for expensive drugs and the presence of favorable reimbursement policies are further attributed to fuel the regional market during the forecast period. Asia-Pacific witnesses significant CAGR over the forecast period heading to technological advances in drug discovery. Growing geriatric population coupled with increased susceptibility to infections is expected to provide a potential growth platform in the forecast period. It was followed by Western Europe and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market.

The objective of the report is to present comprehensive analysis of Global Anti-infective drugs Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

The report also helps in understanding Global Anti-infective drugs Market dynamics, structure by analyzing the market segments, and project the Global market size. Clear representation of competitive analysis of key players by Anti-infective drugs Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Anti-infective drugs Market make the report investor’s guide.

Scope of the Global Anti-infective drugs Market: Inquire before buying






Global Anti-Infective Drugs Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 125.66 Bn.




Forecast Period 2023 to 2029 CAGR:
8%
Market Size in 2029:
US $ 215.36 Bn.




 Segments Covered:
by Product
Antibiotics
Antivirals
Antifungals
Antibacterial




by Distribution Channels
Retail Pharmacy
Hospital Pharmacy
Other






Anti-infective drugs Market by region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Anti-infective drugs Market Key Players are:

1.Gilead Sciences,
2.GlaxoSmithKline,
3.Merck & Co,
4.Teva Pharmaceutical Industries Ltd.,
5.Johnson & Johnson
6.Pfizer Inc.
7.Abbott Laboratories
8.Gilead Sciences, Inc.
9.Bristol-Myers Squibb Co.
10.Bayer Healthcare AG
11.AstraZeneca Plc.
12.Boehringer Ingelheim
13.Novartis AG
14.Astellas Pharma, Inc.
15.GlaxoSmithKline Plc.
16.Alcon Pharmaceuticals Ltd.
17.Sanofi-Aventis S.A.
18.Melinta Therapeutics, Inc.
19.F. Hoffmann-La Roche Ltd
20.Hetero
21.Mylan N.V.
22.Aurobindo Pharma
23.Cipla Inc
24.Laurus Labs Ltd
25.Sun Pharmaceutical Industries Ltd

Frequently Asked questions

1. What is the market size of the Global Anti-Infective Drugs Market in 2022?
Ans. The market size Global market in 2022 was US$ 125.66 Billion.

2. What are the different segments of the Global Anti-Infective Drugs Market?
Ans. The Global market  is divided into Product and Distribution Channel.

3. What is the study period of this market?
Ans. The Global Anti-Infective Drugs Market will be studied from 2022 to 2029.

4. Which region is expected to hold the highest Global Anti-Infective Drugs Market share?
Ans. The Asia Pacific dominates the market share in the  market.

5. What  is the Forecast Period of Global Anti-Infective Drugs Market?
Ans. The Forecast Period of the market is 2023-2029 in the market. 




Global Anti-infective drugs Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Anti-infective drugs Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
4.8. Patent Registration

5. Supply Side and Demand Side Indicators
6. Global Anti-infective drugs Market Analysis and Forecast
6.1. Global Anti-infective drugs Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Anti-infective drugs Market Analysis and Forecast, By Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Anti-infective drugs Market Value Share Analysis, By Product
7.4. Global Anti-infective drugs Market Size (US$ Bn) Forecast, By Product
7.5. Global Anti-infective drugs Market Analysis, By Product
7.6. Global Anti-infective drugs Market Attractiveness Analysis, By Product

8. Global Anti-infective drugs Market Analysis and Forecast, By Distribution Channels
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Anti-infective drugs Market Value Share Analysis, By Distribution Channels
8.4. Global Anti-infective drugs Market Size (US$ Bn) Forecast, By Distribution Channels
8.5. Global Anti-infective drugs Market Analysis, By Distribution Channels
8.6. Global Anti-infective drugs Market Attractiveness Analysis, By Distribution Channels

9. Global Anti-infective drugs Market Analysis, by Region
9.1. Global Anti-infective drugs Market Value Share Analysis, by Region
9.2. Global Anti-infective drugs Market Size (US$ Bn) Forecast, by Region
9.3. Global Anti-infective drugs Market Attractiveness Analysis, by Region

10. North America Anti-infective drugs Market Analysis
10.1. Key Findings
10.2. North America Anti-infective drugs Market Overview
10.3. North America Anti-infective drugs Market Value Share Analysis, By Product
10.4. North America Anti-infective drugs Market Forecast, By Product
10.4.1. Antibiotics,
10.4.2. Antivirals,
10.4.3. Antifungals
10.4.4. Antibacterial
10.5. North America Anti-infective drugs Market Value Share Analysis, By Distribution Channels
10.6. North America Anti-infective drugs Market Forecast, By Distribution Channels
10.6.1. Retail Pharmacy
10.6.2. Hospital Pharmacy
10.6.3. Other
10.7. North America Anti-infective drugs Market Value Share Analysis, by Country
10.8. North America Anti-infective drugs Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Anti-infective drugs Market Analysis, by Country
10.10. U.S. Anti-infective drugs Market Forecast, By Product
10.10.1. Antibiotics,
10.10.2. Antivirals,
10.10.3. Antifungals
10.10.4. Antibacterial
10.11. U.S. Anti-infective drugs Market Forecast, By Distribution Channels
10.11.1. Retail Pharmacy
10.11.2. Hospital Pharmacy
10.11.3. Other
10.12. Canada Anti-infective drugs Market Forecast, By Product
10.12.1. Antibiotics,
10.12.2. Antivirals,
10.12.3. Antifungals
10.12.4. Antibacterial
10.13. Canada Anti-infective drugs Market Forecast, By Distribution Channels
10.13.1. Retail Pharmacy
10.13.2. Hospital Pharmacy
10.13.3. Other
10.14. North America Anti-infective drugs Market Attractiveness Analysis
10.14.1. By Product
10.14.2. By Distribution Channels
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development

11. Europe Anti-infective drugs Market Analysis
11.1. Key Findings
11.2. Europe Anti-infective drugs Market Overview
11.3. Europe Anti-infective drugs Market Value Share Analysis, By Product
11.4. Europe Anti-infective drugs Market Forecast, By Product
11.4.1. Antibiotics,
11.4.2. Antivirals,
11.4.3. Antifungals
11.4.4. Antibacterial
11.5. Europe Anti-infective drugs Market Value Share Analysis, By Distribution Channels
11.6. Europe Anti-infective drugs Market Forecast, By Distribution Channels
11.6.1. Retail Pharmacy
11.6.2. Hospital Pharmacy
11.6.3. Other
11.7. Europe Anti-infective drugs Market Value Share Analysis, by Country
11.8. Europe Anti-infective drugs Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Anti-infective drugs Market Analysis, by Country
11.10. Germany Anti-infective drugs Market Forecast, By Product
11.10.1. Antibiotics,
11.10.2. Antivirals,
11.10.3. Antifungals
11.10.4. Antibacterial
11.11. Germany Anti-infective drugs Market Forecast, By Distribution Channels
11.11.1. Retail Pharmacy
11.11.2. Hospital Pharmacy
11.11.3. Other
11.12. U.K. Anti-infective drugs Market Forecast, By Product
11.12.1. Antibiotics,
11.12.2. Antivirals,
11.12.3. Antifungals
11.12.4. Antibacterial
11.13. U.K. Anti-infective drugs Market Forecast, By Distribution Channels
11.13.1. Retail Pharmacy
11.13.2. Hospital Pharmacy
11.13.3. Other
11.14. France Anti-infective drugs Market Forecast, By Product
11.14.1. Antibiotics,
11.14.2. Antivirals,
11.14.3. Antifungals
11.14.4. Antibacterial
11.15. France Anti-infective drugs Market Forecast, By Distribution Channels
11.15.1. Retail Pharmacy
11.15.2. Hospital Pharmacy
11.15.3. Other
11.16. Italy Anti-infective drugs Market Forecast, By Product
11.16.1. Antibiotics,
11.16.2. Antivirals,
11.16.3. Antifungals
11.16.4. Antibacterial
11.17. Italy Anti-infective drugs Market Forecast, By Distribution Channels
11.17.1. Retail Pharmacy
11.17.2. Hospital Pharmacy
11.17.3. Other
11.18. Spain Anti-infective drugs Market Forecast, By Product
11.18.1. Antibiotics,
11.18.2. Antivirals,
11.18.3. Antifungals
11.18.4. Antibacterial
11.19. Spain Anti-infective drugs Market Forecast, By Distribution Channels
11.19.1. Retail Pharmacy
11.19.2. Hospital Pharmacy
11.19.3. Other
11.20. Rest of Europe Anti-infective drugs Market Forecast, By Product
11.20.1. Antibiotics,
11.20.2. Antivirals,
11.20.3. Antifungals
11.20.4. Antibacterial
11.21. Rest of Europe Anti-infective drugs Market Forecast, By Distribution Channels
11.21.1. Retail Pharmacy
11.21.2. Hospital Pharmacy
11.21.3. Other
11.22. Europe Anti-infective drugs Market Attractiveness Analysis
11.22.1. By Product
11.22.2. By Distribution Channels
11.23. PEST Analysis
11.24. Key Trend
11.25. Key Development

12. Asia Pacific Anti-infective drugs Market Analysis
12.1. Key Findings
12.2. Asia Pacific Anti-infective drugs Market Overview
12.3. Asia Pacific Anti-infective drugs Market Value Share Analysis, By Product
12.4. Asia Pacific Anti-infective drugs Market Forecast, By Product
12.4.1. Antibiotics,
12.4.2. Antivirals,
12.4.3. Antifungals
12.4.4. Antibacterial
12.5. Asia Pacific Anti-infective drugs Market Value Share Analysis, By Distribution Channels
12.6. Asia Pacific Anti-infective drugs Market Forecast, By Distribution Channels
12.6.1. Retail Pharmacy
12.6.2. Hospital Pharmacy
12.6.3. Other
12.7. Asia Pacific Anti-infective drugs Market Value Share Analysis, by Country
12.8. Asia Pacific Anti-infective drugs Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Anti-infective drugs Market Analysis, by Country
12.10. China Anti-infective drugs Market Forecast, By Product
12.10.1. Antibiotics,
12.10.2. Antivirals,
12.10.3. Antifungals
12.10.4. Antibacterial
12.11. China Anti-infective drugs Market Forecast, By Distribution Channels
12.11.1. Retail Pharmacy
12.11.2. Hospital Pharmacy
12.11.3. Other
12.12. India Anti-infective drugs Market Forecast, By Product
12.12.1. Antibiotics,
12.12.2. Antivirals,
12.12.3. Antifungals
12.13. India Anti-infective drugs Market Forecast, By Distribution Channels
12.13.1. Retail Pharmacy
12.13.2. Hospital Pharmacy
12.13.3. Other
12.14. Japan Anti-infective drugs Market Forecast, By Product
12.14.1. Antibiotics,
12.14.2. Antivirals,
12.14.3. Antifungals
12.14.4. Antibacterial
12.15. Japan Anti-infective drugs Market Forecast, By Distribution Channels
12.15.1. Retail Pharmacy
12.15.2. Hospital Pharmacy
12.15.3. Other
12.16. ASEAN Anti-infective drugs Market Forecast, By Product
12.16.1. Antibiotics,
12.16.2. Antivirals,
12.16.3. Antifungals
12.16.4. Antibacterial
12.17. ASEAN Anti-infective drugs Market Forecast, By Distribution Channels
12.17.1. Retail Pharmacy
12.17.2. Hospital Pharmacy
12.17.3. Other
12.18. Rest of Asia Pacific Anti-infective drugs Market Forecast, By Product
12.18.1. Antibiotics,
12.18.2. Antivirals,
12.18.3. Antifungals
12.18.4. Antibacterial
12.19. Rest of Asia Pacific Anti-infective drugs Market Forecast, By Distribution Channels
12.19.1. Retail Pharmacy
12.19.2. Hospital Pharmacy
12.19.3. Other
12.20. Asia Pacific Anti-infective drugs Market Attractiveness Analysis
12.20.1. By Product
12.20.2. By Distribution Channels
12.21. PEST Analysis
12.22. Key Trend
12.23. Key Development

13. Middle East & Africa Anti-infective drugs Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Anti-infective drugs Market Overview
13.3. Middle East & Africa Anti-infective drugs Market Value Share Analysis, By Product
13.4. Middle East & Africa Anti-infective drugs Market Forecast, By Product
13.4.1. Antibiotics
13.4.2. Antivirals
13.4.3. Antifungals
13.4.4. Antibacterial
13.5. Middle East & Africa Anti-infective drugs Market Value Share Analysis, By Distribution Channels
13.6. Middle East & Africa Anti-infective drugs Market Forecast, By Distribution Channels
13.6.1. Retail Pharmacy
13.6.2. Hospital Pharmacy
13.6.3. Other
13.7. Middle East & Africa Anti-infective drugs Market Value Share Analysis, by Country
13.8. Middle East & Africa Anti-infective drugs Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Anti-infective drugs Market Analysis, by Country
13.10. GCC Anti-infective drugs Market Forecast, By Product
13.10.1. Antibiotics
13.10.2. Antivirals
13.10.3. Antifungals
13.10.4. Antibacterial
13.11. GCC Anti-infective drugs Market Forecast, By Distribution Channels
13.11.1. Retail Pharmacy
13.11.2. Hospital Pharmacy
13.11.3. Other
13.12. South Africa Anti-infective drugs Market Forecast, By Product
13.12.1. Antibiotics
13.12.2. Antivirals
13.12.3. Antifungals
13.12.4. Antibacterial
13.13. South Africa Anti-infective drugs Market Forecast, By Distribution Channels
13.13.1. Retail Pharmacy
13.13.2. Hospital Pharmacy
13.13.3. Other
13.14. Rest of Middle East & Africa Anti-infective drugs Market Forecast, By Product
13.14.1. Antibiotics,
13.14.2. Antivirals,
13.14.3. Antifungals
13.14.4. Antibacterial
13.15. Rest of Middle East & Africa Anti-infective drugs Market Forecast, By Distribution Channels
13.15.1. Retail Pharmacy
13.15.2. Hospital Pharmacy
13.15.3. Other
13.16. Middle East & Africa Anti-infective drugs Market Attractiveness Analysis
13.16.1. By Product
13.16.2. By Distribution Channels
13.17. PEST Analysis
13.18. Key Trend
13.19. Key Development

14. South America Anti-infective drugs Market Analysis
14.1. Key Findings
14.2. South America Anti-infective drugs Market Overview
14.3. South America Anti-infective drugs Market Value Share Analysis, By Product
14.4. South America Anti-infective drugs Market Forecast, By Product
14.4.1. Antibiotics,
14.4.2. Antivirals,
14.4.3. Antifungals
14.4.4. Antibacterial
14.5. South America Anti-infective drugs Market Value Share Analysis, By Distribution Channels
14.6. South America Anti-infective drugs Market Forecast, By Distribution Channels
14.6.1. Retail Pharmacy
14.6.2. Hospital Pharmacy
14.6.3. Other
14.7. South America Anti-infective drugs Market Value Share Analysis, by Country
14.8. South America Anti-infective drugs Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. Brazil Anti-infective drugs Market Forecast, By Product
14.9.1. Antibiotics,
14.9.2. Antivirals,
14.9.3. Antifungals
14.9.4. Antibacterial
14.10. Brazil Anti-infective drugs Market Forecast, By Distribution Channels
14.10.1. Retail Pharmacy
14.10.2. Hospital Pharmacy
14.10.3. Other
14.11. Mexico Anti-infective drugs Market Forecast, By Product
14.11.1. Antibiotics,
14.11.2. Antivirals,
14.11.3. Antifungals
14.11.4. Antibacterial
14.12. Mexico Anti-infective drugs Market Forecast, By Distribution Channels
14.12.1. Retail Pharmacy
14.12.2. Hospital Pharmacy
14.12.3. Other
14.13. Rest of South America Anti-infective drugs Market Forecast, By Product
14.13.1. Antibiotics,
14.13.2. Antivirals,
14.13.3. Antifungals
14.13.4. Antibacterial
14.14. Rest of South America Anti-infective drugs Market Forecast, By Distribution Channels
14.14.1. Retail Pharmacy
14.14.2. Hospital Pharmacy
14.14.3. Other
14.15. South America Anti-infective drugs Market Attractiveness Analysis
14.15.1. By Product
14.15.2. By Distribution Channels
14.16. PEST Analysis
14.17. Key Trend
14.18. Key Development

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Gilead Sciences
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Company Footprint
15.3.2. GlaxoSmithKline,
15.3.3. Merck & Co,
15.3.4. Teva Pharmaceutical Industries Ltd.,
15.3.5. Johnson & Johnson
15.3.6. Pfizer Inc.
15.3.7. Abbott Laboratories
15.3.8. Gilead Sciences, Inc.
15.3.9. Bristol-Myers Squibb Co.
15.3.10. Merck and Co., Inc.
15.3.11. Bayer Healthcare AG
15.3.12. AstraZeneca Plc.
15.3.13. Boehringer IngelheimNovartis AG
15.3.14. Astellas Pharma, Inc.
15.3.15. GlaxoSmithKline Plc.
15.3.16. Alcon Pharmaceuticals Ltd.
15.3.17. Sanofi-Aventis S.A.
15.3.18. Johnson and Johnson
15.3.18. F. Hoffmann-La Roche Ltd
15.3.19. Hetero
15.3.20. Mylan N.V.
15.3.21. Aurobindo Pharma
15.3.22. Cipla Inc
15.3.23. Laurus Labs Ltd
15.3.24. Sun Pharmaceutical Industries Ltd

16. Primary Key Insights
  • INQUIRE BEFORE BUYING